• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Aspects of the absorption of oral L-thyroxine in normal man.

作者信息

Wenzel K W, Kirschsieper H E

出版信息

Metabolism. 1977 Jan;26(1):1-8. doi: 10.1016/0026-0495(77)90121-4.

DOI:10.1016/0026-0495(77)90121-4
PMID:834138
Abstract

Using a double isotope method, the optimal conditions for the absorption of an L-thyroxine (L-T4) preparation were examined. In particular, the influence of food intake on L-T4 absorption was examined. As distinct from the unfavorable results hitherto obtained with L-T4 lactase mixtures, a tablet similar to a commercial 100 mug L-T4 lactose preparation showed good absorptionof 70.6% +/- 12.9% SD. In the fasting state, the L-T4 absorption of both preparations was significantly better (p less than 0.001) than with simultaneous food intake: 79.3% +/- 7.2% SD versus 63.9% +/- 10.5% SD. The calculated absorption of a 3-mg L-T4 dose in a lactose preparation used in testing thyroid suppressibility was significantly lower (p less than 0.001) than the absorption of a smaller L-T4 dose, and the absorption in the fasting state was again signifiantly (; less than 0.01) higher compared to that with simultaneous food intake: 52.6% +/- 4.3% SD versus 43.9% +/- 5.4% SD. The possibility of retention in the liver in the case of a large 3-mg L-T4 dose is indicated. The data suggest that with L-thyroxine medication simultaneous food intake should be avoided.

摘要

相似文献

1
Aspects of the absorption of oral L-thyroxine in normal man.
Metabolism. 1977 Jan;26(1):1-8. doi: 10.1016/0026-0495(77)90121-4.
2
Human thyroxine absorption: age effects and methodological analyses.人体甲状腺素吸收:年龄影响及方法学分析。
Thyroid. 1994 Spring;4(1):55-64. doi: 10.1089/thy.1994.4.55.
3
Pharmacokinetics of total thyroxine in dogs after administration of an oral solution of levothyroxine sodium.左甲状腺素钠口服溶液给药后犬体内总甲状腺素的药代动力学
J Vet Pharmacol Ther. 2008 Apr;31(2):95-101. doi: 10.1111/j.1365-2885.2007.00935.x.
4
Ciprofloxacin and rifampin have opposite effects on levothyroxine absorption.环丙沙星和利福平对左甲状腺素的吸收有相反的影响。
Thyroid. 2013 Nov;23(11):1374-8. doi: 10.1089/thy.2013.0014. Epub 2013 Oct 16.
5
[Posologic equivalents of oral L-thyroxine in thyroid insufficiency (120 cases)].[甲状腺功能减退症中口服左甲状腺素的等效剂量(120例)]
Ann Med Interne (Paris). 1983;134(7):636-42.
6
The administration of L-thyroxine as soft gel capsule or liquid solution.左甲状腺素的给药途径可以是软胶囊或液体制剂。
Expert Opin Drug Deliv. 2014 Jul;11(7):1103-11. doi: 10.1517/17425247.2014.918101. Epub 2014 Jun 4.
7
Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine.乳糖不耐受作为口服甲状腺素需求增加原因的系统评价。
J Clin Endocrinol Metab. 2014 Aug;99(8):E1454-8. doi: 10.1210/jc.2014-1217. Epub 2014 May 5.
8
Localization of human thyroxine absorption.人甲状腺素吸收的定位
Thyroid. 1991 Summer;1(3):241-8. doi: 10.1089/thy.1991.1.241.
9
Comparison of the effect of a single oral L-thyroxine dose (150 micrograms) in tablet and in solution on serum thyroxine and TSH concentrations.单次口服150微克片剂和溶液剂左甲状腺素对血清甲状腺素和促甲状腺激素浓度影响的比较。
Thyroidology. 1993 Apr;5(1):9-12.
10
Bioavailability of thyroid hormones from oral replacement preparations.口服替代制剂中甲状腺激素的生物利用度。
Metabolism. 1982 Sep;31(9):900-5. doi: 10.1016/0026-0495(82)90179-2.

引用本文的文献

1
Therapeutic efficacy and patient compliance of levothyroxine liquid and softgel formulations taken with meals: a systematic review.左甲状腺素液体制剂和软胶囊制剂随餐服用的治疗效果及患者依从性:一项系统评价
Endocrine. 2025 Jan;87(1):48-58. doi: 10.1007/s12020-024-04016-7. Epub 2024 Aug 31.
2
Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose.乳糖不耐受和左甲状腺素吸收不良:文献复习及一组用不含乳糖的液体 L-T4 治疗的患者报告。
Front Endocrinol (Lausanne). 2024 Apr 11;15:1386510. doi: 10.3389/fendo.2024.1386510. eCollection 2024.
3
Levothyroxine personalized treatment: is it still a dream?
左甲状腺素个体化治疗:是否仍为梦想?
Front Endocrinol (Lausanne). 2024 Jan 8;14:1334292. doi: 10.3389/fendo.2023.1334292. eCollection 2023.
4
Medications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic Review.影响左甲状腺素生物利用度的药物与食物:一项系统评价
Ther Clin Risk Manag. 2023 Jun 23;19:503-523. doi: 10.2147/TCRM.S414460. eCollection 2023.
5
Improper administration: Silent culprit of drug therapy problems.用药不当:药物治疗问题的隐性罪魁祸首。
Can Fam Physician. 2023 Feb;69(2):107-112. doi: 10.46747/cfp.6902107.
6
Increased fT4 concentrations in patients using levothyroxine without complete suppression of TSH.使用左甲状腺素的患者游离甲状腺素(fT4)浓度升高,促甲状腺激素(TSH)未被完全抑制。
Endocr Connect. 2023 Mar 20;12(4). doi: 10.1530/EC-22-0538. Print 2023 Apr 1.
7
Approach to adult patients with primary hypothyroidism in some special situations: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM).成人原发性甲状腺功能减退症某些特殊情况下的处理方法:巴西内分泌学会甲状腺分会的立场声明。
Arch Endocrinol Metab. 2022 Nov 17;66(6):871-882. doi: 10.20945/2359-3997000000545.
8
Evaluation of Bedtime vs. Morning Levothyroxine Intake to Control Hypothyroidism in Older Patients: A Pragmatic Crossover Randomized Clinical Trial.评估老年患者睡前与晨起服用左甲状腺素以控制甲状腺功能减退:一项实用交叉随机临床试验
Front Med (Lausanne). 2022 Jun 23;9:828762. doi: 10.3389/fmed.2022.828762. eCollection 2022.
9
An Overview on Different L-Thyroxine (l-T) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.不同左甲状腺素(l-T)制剂概述及可能影响生命最初 3 年先天性甲状腺功能减退症治疗的因素。
Front Endocrinol (Lausanne). 2022 Jun 9;13:859487. doi: 10.3389/fendo.2022.859487. eCollection 2022.
10
Pharmacokinetics and Clinical Implications of Two Non-Tablet Oral Formulations of L-Thyroxine in Patients with Hypothyroidism.左旋甲状腺素两种非片剂口服制剂在甲状腺功能减退患者中的药代动力学及临床意义
J Clin Med. 2022 Jun 16;11(12):3479. doi: 10.3390/jcm11123479.